Synthesis of Novel Chain Extended and Crosslinked Polylactones for Tissue Regeneration and Controlled Release Applications

Author(s):  
Jukka Seppälä ◽  
Harri Korhonen ◽  
Risto Hakala ◽  
Minna Malin
2014 ◽  
pp. 4709 ◽  
Author(s):  
Dinesh Kumar Srinivasan ◽  
Chinnasamy Gandhimathi ◽  
Jayarama Reddy Venugopal ◽  
Velmurugan Bhaarathy ◽  
Seeram Ramakrishna

Biomaterials ◽  
2006 ◽  
Vol 27 (34) ◽  
pp. 5836-5844 ◽  
Author(s):  
Hossein Hosseinkhani ◽  
Mohsen Hosseinkhani ◽  
Ali Khademhosseini ◽  
Hisatoshi Kobayashi ◽  
Yasuhiko Tabata

Author(s):  
Ibrahim T. Ozbolat ◽  
A. K. M. B. Khoda ◽  
Bahattin Koc

Development of engineered tissue scaffolds with superior control over cell-protein interactions is still very much infancy. Advancing through heterogeneous multifold scaffolds with controlled release fashion enables synchronization of regenerating tissue with the release kinetics of loaded biomolecules. This might be an engineering challenge and promising approach for improved and efficient tissue regeneration. The most critical limitations: the selection of proper protein(s) incorporation, and precise control over concentration gradient and timing should be overcome. Hence, tissue scaffolds need to be fabricated in a way that proteins or growth factors should be incorporated and released in a specific spatial and temporal orientation to mimic the natural tissue regeneration process. Spatial and temporal control over heterogeneous porous tissue scaffolds can be achieved by controlling two important parameters: (i) internal architecture with enhanced fluid transport, and (ii) distribution of scaffold base material and loaded modifiers. In this research, heterogeneous tissue scaffolds are designed considering both the parameters. Firstly, the three-dimensional porous structures of the scaffold are geometrically partition into functionally uniform porosity regions and controlled spatial micro-architecture has been achieved using a functionally gradient porosity function. The bio-fabrication of the designed internal porous architecture has been performed using a single nozzle bioadditive manufacturing system. The internal architecture scheme is developed to enhance fluid transport with continuous base material deposition. Next, the hybrid tissue scaffolds are modeled with varying material characteristics to mediate the release of base material and enclosed biological modifiers are proposed based on tissue engineering requirements. The hybrid scaffolds are fabricated for spatial control of biomolecules and base material to synchronize the release kinetics with tissue regeneration. A pressure-assisted multi-chamber single nozzle bioadditive manufacturing system is used to fabricate hybrid scaffolds.


2013 ◽  
Vol 19 (11-12) ◽  
pp. 1398-1405 ◽  
Author(s):  
Ran Ito ◽  
Naoki Morimoto ◽  
Liem Hieu Pham ◽  
Tsuguyoshi Taira ◽  
Katsuya Kawai ◽  
...  

2019 ◽  
Vol 20 (23) ◽  
pp. 5850 ◽  
Author(s):  
Lee ◽  
Trinh ◽  
Yoo ◽  
Shin ◽  
Lee ◽  
...  

Self-assembling peptides are biomedical materials with unique structures that are formed in response to various environmental conditions. Governed by their physicochemical characteristics, the peptides can form a variety of structures with greater reactivity than conventional non-biological materials. The structural divergence of self-assembling peptides allows for various functional possibilities; when assembled, they can be used as scaffolds for cell and tissue regeneration, and vehicles for drug delivery, conferring controlled release, stability, and targeting, and avoiding side effects of drugs. These peptides can also be used as drugs themselves. In this review, we describe the basic structure and characteristics of self-assembling peptides and the various factors that affect the formation of peptide-based structures. We also summarize the applications of self-assembling peptides in the treatment of various diseases, including cancer. Furthermore, the in-cell self-assembly of peptides, termed reverse self-assembly, is discussed as a novel paradigm for self-assembling peptide-based nanovehicles and nanomedicines.


Sign in / Sign up

Export Citation Format

Share Document